Abstract
We decided to assess the prognostic value of NLRP3 inflammasome level in acute coronary syndrome (ACS) patients and whether it was related to coronary atherosclerotic severity. Study population included one-hundred and twenty-three (123) subjects. Peripheral blood monocyte NLRP3 protein level was correlated with clinical presentation, angiographic characteristics and its scoring systems as well as GRACE and TIMI risk scores. Follow-up for major adverse cardiac events (MACE) was carried out at 180 days. Peripheral blood monocyte NLRP3 was found to be elevated in ACS patients (P < 0.05) and showed positive correlation with GRACE score (r = 0.619), TIMI score (r = 0.580), SYNTAX score (r = 0.550), Clinical SYNTAX score (r = 0.564) and Gensini score (r = 0.516). NLRP3 was also increased with increasing number of vessels, the number of lesions present and the presence bifurcation lesions (P < 0.05). Multivariate Cox regression analysis showed NLRP3 to be an independent predictor of MACE (P = 0.043). Kaplan–Meier analysis and receiver operating characteristic curves for NLRP3 showed good predictive value for MACE. There is a positive correlation of NLRP3 level with severity of coronary atherosclerosis. NLRP3 level is a promising prognostic utility and is efficient in event prediction for MACE.
Similar content being viewed by others
References
Katritsis D, Korovesis S, Giazitzoglou E, Parissis J, Kalivas P, Webb-Peploe MM, Ioannidis JP, Haliassos A (2001) C-reactive protein concentrations and angiographic characteristics of coronary lesions. Clin Chem 47(5):882–886
Rajamaki K, Lappalainen J (2010) Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One 5:e11765
Coll RC, O’Neill LA (2010) New insights into the regulation of signalling by toll-like receptors and nod-like receptors. J Innate Immun 2:406–421
Palmerini T, Genereux P, Caixeta A, Cristea E, Lansky A, Mehran R, Dangas G, Lazar D, Sanchez R, Fahy M, Xu K, Stone GW (2011) Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention. J Am Coll Cardiol 57(24):2389–2397
Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C (2009) Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2(4):302–308
Kim YH, Park DW, Kim WJ, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ (2010) Validation of SYNTAX (synergy between PCI with taxus and cardiac surgery) score for prediction of outcomes after unprotected left main coronary revascularization. JACC Cardiovasc Interv 3(6):612–623
Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP, Investigators ARTSII (2010) 5-year clinical outcomes of the ARTS II (arterial revascularization therapies study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 55(11):1093–1101
van Gaal WJ, Ponnuthurai FA, Selvanayagam J, Testa L, Porto I, Neubauer S, Banning AP (2009) The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol 135(1):60–65
Wykrzykowska JJ, Garg S, Girasis C, Vries TD, More MA, GAV ES, Buszman P, Linke A, Ischinger T, Klauss V, Corti R, Eberli F, Wijns W, Morice MC, Mario CD, Geuns RJV, Juni P, Windecker S, Serruys PW (2010) Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) Trial. JACC 56(4):272–277
Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 1(2):219–227
Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW (2009) Assessment of the SYNTAX score in the Syntax study. Eurointervention 5(1):50–56
Kato S, Saito N, Kirigaya H, Gyotoku D, Iinuma N, Kusakawa Y, Iguchi K, Nakachi T, Fukui K, Futaki M, Iwasawa T, Taguri M, Kimura K, Umemura S (2015) Incremental prognostic value of the SYNTAX score to late gadolinium-enhanced magnetic resonance images for patients with stable coronary artery disease. Heart Vessels. doi:10.1007/s00380-015-0685-x
Gensini GG (1983) A more meaningful scoring system for deter-mining the severity of coronary heart disease. Am J Cardiol 51(3):606
Garg S, Sarno G, Garcia-Garcia HM, Girasis C, Wykrzykowska J, Dawkins KD, Serruys PW, Investigators ARTS-II (2010) A new tool for the risk stratification of patients with complex coronary artery disease: the clinical SYNTAX score. Circ Cardiovasc Interv 3(4):317–326
Ranucci M, Castelvecchio S, Menicanti L, Frigiola A, Pelissero G (2009) Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony. Circulation 119(24):3053–3061
Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the,2002Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine Circulation 116 (7):e148–e148
Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W (2007) Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the european society of cardiology. Eur Heart J 28(13):1598–1660
Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, De Van, Werf F, Avezum A, Goodman SG, Flather MD, Fox KA (2003) Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163(19):2345–2353
Ramsay G, Podogrodzka M, Mcclure C, Fox KA (2007) Risk prediction in patients presenting with suspected cardiac pain: the GRACE and TIMI risk scores versus clinical evaluation. Q J M 100(1):11–18
Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC Jr, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) (2002) ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction-2002: Summary Article: A report of the AmericanCollege of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 106(14):1893–1900
Davies JQ, Gordon S (2005) Isolation and culture of human macrophages. Methods Mol Biol 290:105–116
Margolis JR, Gillum RF, Feinleib M, Brasch RC, Fabsitz RR (1974) Community surveillance for coronary heart disease: the Framingham cardiovascular disease survey Methods and preliminary results. Am J Epidemoil 100(6):425–436
Rifai N, Joubran R, Yu H, Jouma M (1999) Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 45(11):1967–1973
Zheng F, Xing S, Gong Z, Xing Q (2013) NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis. Heart Lung Circ. 22(9):746–750
Satoh M, Tabuchi T, Itoh T, Nakamura M (2014) NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin. Clin Sci 126(3):233–241
Xian WC, Zhe H, Masafumi K, Kenji O, Toyoaki M (2011) Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. Hypertension 58:978–986
Cassel SL, Joly S (2009) The NLRP3 inflammasome: a sensor of immune danger signals. Semin Immunol 21:194–198
Kawamura A, Baitsch D, Telgmann R, Feuerborn R, Weissen-Plenz G, Hagedorn C, Saku K, Brand-Herrmann SM, von Eckardstein A, Assmann G, Nofer JR (2007) Apolipoprotein E interrupts interleukin-1β signaling in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 27:1610–1617
Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ (2002) AtheroGene Investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 106:24–30
Benetti E, Chiazza F, Patel NS, Collino M (2013) The NLRP3 inflammasome as a novel player of the intercellular crosstalk in metabolic disorders. mediators of inflammation. Mediators Inflamm. doi:10.1155/2013/678627
Oda E, Goto M, Matsushita H, Takarada K, Tomita M, Saito A, Fuse K, Fujita S, Ikeda Y, Kitazawa H, Takahashi M, Sato M, Okabe M, Aizawa Y (2013) The association between obesity and acute myocardial infarction is age- and gender-dependent in a Japanese population. Heart Vessels 28:551–558
Kajiya M, Miyoshi T, Doi M, Usui S, Iwamoto M, Takeda K, Nosaka K, Nakayama R, Hirohata S, Kusachi S, Nakamura K, Ito H (2013) Serum adipocyte fatty acid-binding protein is independently associated with complex coronary lesions in patients with stable coronary artery disease. Heart Vessels 28(6):696–703
Ito H, Motoyama S, Sarai M, Kawai H, Harigaya H, Kan S, Kato S, Anno H, Takahashi H, Naruse H, Ishii J, Narula J, Ozaki Y (2014) Characteristics of plaque progression detected by serial coronary computed tomography angiography. Heart Vessels 29(6):743–749
Takaoka N, Tsujita K, Kaikita K, Hokimoto S, Yamanaga K, Komura N, Chitose T, Ono T, Mizobe M, Horio E, Sato K, Nakayama N, Saito M, Iwashita S, Kojima S, Tayama S, Sugiyama S, Nakamura S, Ogawa H (2014) Intravascular ultrasound morphology of culprit lesions and clinical demographics in patients with acute coronary syndrome in relation to low-density lipoprotein cholesterol levels at onset. Heart Vessels 29(5):584–595
Dominic DN, Eicke L (2011) NLRP3 inflammasome link inflammation and metabolic disease. Trends Immunol 32(8):373–379
Shao L, Zhang P, Zhang Y, Lu Q, Ma A (2014) TLR3 and TLR4 as potential clinically biomarkers of cardiovascular risk in coronary artery disease (CAD) patients. Heart Vessels 29(5):690–698
Kang MJ, Homer RJ, Gallo A, Lee CG, Crothers KA, Cho SJ, Rochester C, Cain H, Chupp G, Yoon HJ, Elias JA (2007) IL-18 is induced and IL-18 receptor α plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J Immunol 178(3):1948–1959
Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA, GRACE Investigators (2004) A validated prediction model for all forms of acute coronary syndrome. Estimating the risk of 6-month postdischarge death in an international registry. JAMA 291(22):2727–2733
The GRACE investigators (2001) Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalised with acute coronary syndromes. Am Heart J 141(2):190–199
Pollack CV Jr, Sites FD, Shofer FS, Sease KL, Hollander JE (2006) Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. Acad Emerg Med 13(1):13–18
Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E (2000) TIMI Risk Score for ST-Elevation Myocardial Infarction: a Convenient, Bedside, Clinical Score for Risk Assessment at Presentation An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation 102(17):2031–2037
Pauwels NS, Bracke KR, Dupont LL, Van Pottelberge GR, Provoost S, Vanden Berghe T, Vandenabeele P, Lambrecht BN, Joos GF, Brusselle GG (2011) Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J 38(5):1019–1028
Maes T, Bracke KR, Vermaelen KY, Demedts IK, Joos GF, Pauwels RA, Brusselle GG (2006) Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol 141(4):354–368
Qu Y, Franchi L, Nunez G, Dubyak GR (2007) Nonclassical IL-1β secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 179(3):1913–1925
Mariathasan S, Monack DM (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7(1):31–40
Sutterwala FS, Ogura Y, Zamboni DS, Roy CR, Flavell RA (2006) NALP3: a key player in caspase-1 activation. J Endotoxin Res 12(4):251–256
Hou C, Zhao H, Liu L, Li W, Zhou X, Lv Y, Shen X, Liang Z, Cai S, Zou F (2011) High mobility group protein B1 (HMGB1) in asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls. Mol Med 17(7):807–815
Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, Melloni E, Presta M (2006) Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol 176(1):12–15
Ong AT, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR Jr, Mack MJ, van den Brand M, Morel MA, van Es GA, Kleijne J, Koglin J, Russell ME (2006) The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 151(6):1194–1204
Lansky AJ, Goto K, Cristea E, Fahy M, Parise H, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Mehran R, Moses J, Leon M, Stone GW (2010) Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. Circ Cardiovasc Interv 3(4):308–316
Rouleau JL, Talajic M, Sussex B, Potvin L, Warnica W, Davies RF, Gardner M, Stewart D, Plante S, Dupuis R, Lauzon C, Ferguson J, Mikes E, Balnozan V, Savard P (1996) Myocardial infarction patients in the 1990s: their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. JACC 27(5):1119–1127
Noda M, Takagi A, Kuwatsuru R, Mitsuhashi N, Kasanuki H (2008) Prognostic significance of multiple-detector computed tomography in conjunction with TIMI risk score for patients with non-ST elevation acute coronary syndrome. Heart Vessels 23(3):161–166
Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A, Goodman SG, Flather MD, Anderson FA Jr, Granger CB (2006) Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333(7578):1091
Squire IB, O’Brien RJ, Demme B, Davies JE, Ng LL (2004) N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Clin Sci 107(3):309–316
Lagerqvist B, Diderholm E, Lindahl B, Husted S, Kontny F, Ståhle E, Swahn E, Venge P, Siegbahn A, Wallentin L (2005) FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease. Heart 91(8):1047–1052
Maseri A, Rebuzzi AG, Cianflone D (1997) Need for a composite risk stratification of patients with unstable coronary syndromes tailored to clinical practice. Circulation 96(12):4141–4142
Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock: sHOCK Investigators: should we emergently revascularize occluded coronaries for cardiogenic shock. NEJM 341(9):625–634
Mark DB. Medical economics in cardiovascular medicine. In: Topol EJ, ed. (1998) Textbook of Cardiovascular Medicine 1033–1061
Newby LK, Califf RM, Guerci A, Weaver WD, Col J, Horgan JH, Mark DB, Stebbins A, Van de Werf F, Gore JM, Topol EJ, GUSTO Investigators (1996) Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for OccludedCoronary Arteries (GUSTO) trial. JACC 27(3):625–632
Antman EM, Kuntz KM (2000) The length of the hospital stay after myocardial infarction. NEJM 342:808–810
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics statement
Our study abided by the Declaration of Helsinki and the ethics committee of our hospital approved the protocol for the study. We also obtained written and informed consent from all participants included in the study.
Funding
National nature science foundation of China (No. 30670836).
Rights and permissions
About this article
Cite this article
Afrasyab, A., Qu, P., Zhao, Y. et al. Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients. Heart Vessels 31, 1218–1229 (2016). https://doi.org/10.1007/s00380-015-0723-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-015-0723-8